Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inBiotechnology

Tracing Lead in Ambient Air from Wood Combustion

April 22, 2026
Continue Reading
tracing-lead-in-ambient-air-from-wood-combustion
Posted inBiotechnology

Brain Blood Flow in Teens After Infant Heart Surgery

April 22, 2026
Continue Reading
brain-blood-flow-in-teens-after-infant-heart-surgery
Posted inBiotechnology

AI-Powered Decision Support Boosts Donor Heart Utilization for Transplants

April 22, 2026
Continue Reading
ai-powered-decision-support-boosts-donor-heart-utilization-for-transplants
Posted inBiotechnology

Portable Air Cleaners Reduce Indoor Pollution, Improve Perception

April 22, 2026
Continue Reading
portable-air-cleaners-reduce-indoor-pollution,-improve-perception
Posted inBiotechnology

DNA Methyltransferase 3a Loss Sparks Cardiomyocyte Pyroptosis

April 22, 2026
Continue Reading
dna-methyltransferase-3a-loss-sparks-cardiomyocyte-pyroptosis
Posted inBiotechnology

Economic Models in Neonatal Intensive Care: A Review

April 22, 2026
Continue Reading
economic-models-in-neonatal-intensive-care:-a-review
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

ai-expedites-motor-neuron-analysis-and-screening-in-als-research
Posted inGenetics

AI Expedites Motor Neuron Analysis and Screening in ALS Research

December 20, 2024
Developing motor neurons from stem cells taken directly from amyotrophic lateral sclerosis (ALS) patients offers new hope for better understanding…
Read More
fda-rejects-zealand-pharma’s-glp-2-analog-in-rare-bowel-disease
Posted inBiotechnology

FDA rejects Zealand Pharma’s GLP-2 analog in rare bowel disease

December 19, 2024
The FDA has denied Zealand Pharma’s approval bid for glepaglutide—a possible challenger to Takeda’s Gattex—in short bowel syndrome (SBS), citing…
Read More
flu-vaccine-response-boosted-by-coupling-antigens-from-multiple-subtypes
Posted inGenetics

Flu Vaccine Response Boosted by Coupling Antigens from Multiple Subtypes

December 19, 2024
The seasonal influenza vaccine contains strains of viruses from distinct virus subtypes, but most people who are vaccinated will mount…
Read More
pyxis-oncology-shelves-antibody-to-focus-on-sole-clinical-asset,-an-adc-licensed-from-pfizer
Posted inBiotechnology

Pyxis Oncology shelves antibody to focus on sole clinical asset, an ADC licensed from Pfizer

December 19, 2024
Pyxis Oncology is shelving a clinical-stage monoclonal antibody to focus on its lead antibody-drug conjugate (ADC) after sharing preliminary results…
Read More
oncology-biotech-epitopea-licenses-genevant-nucleic-acid-delivery-tech-for-up-to-$123m
Posted inBiotechnology

Oncology biotech Epitopea licenses Genevant nucleic acid delivery tech for up to $123M

December 19, 2024
To develop RNA medicines targeting a proprietary bundle of tumor antigens, Epitopea is tapping nucleic acid delivery specialist Genevant Sciences…
Read More
chutes-&-ladders—fda’s-principal-deputy-to-depart-agency
Posted inBiotechnology

Chutes & Ladders—FDA’s principal deputy to depart agency

December 19, 2024
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please…
Read More
omeros-antibody-improves-overall-survival-by-68%-in-rare-condition,-new-analysis-finds
Posted inBiotechnology

Omeros antibody improves overall survival by 68% in rare condition, new analysis finds

December 19, 2024
Omeros is putting up its monoclonal antibody up for FDA approval—again. This time, the resubmission will be based on a…
Read More
merck’s-hiv-combo-treatment-meets-the-bar-for-viral-suppression-in-pair-of-phase-3-studies
Posted inBiotechnology

Merck’s HIV combo treatment meets the bar for viral suppression in pair of phase 3 studies

December 19, 2024
After hitting the mark in a phase 2 of its investigational islatravir paired with Gilead’s lenacapivir, Merck & Co.'s islatravir…
Read More
vc-firm-pens-$608m-biobucks-deal-to-redirect-ngm’s-mash-drug-to-rare-disease
Posted inBiotechnology

VC firm pens $608M biobucks deal to redirect NGM’s MASH drug to rare disease

December 19, 2024
KdT Ventures has signed off on a $608 million biobucks deal for NGM Biopharmaceuticals’ phase 2-ready metabolic-dysfunction associated steatohepatitis (MASH)…
Read More
scinai-immunotherapeutics-establishes-us.-cdmo-subsidiary
Posted inGenetics

Scinai Immunotherapeutics Establishes U.S. CDMO Subsidiary

December 19, 2024
Scinai Immunotherapeutics, which focuses on developing inflammation and immunology biological products and providing CDMO services through its Scinai Bioservices business…
Read More

Posts pagination

Previous page 1 … 1,706 1,707 1,708 1,709 1,710 … 1,721 Next page
You May Have Missed
pulnovo-medical-scores-$100m-in-finance-round-led-by-medtronic
Posted inMedical Technology

Pulnovo Medical scores $100M in finance round led by Medtronic

foundation-medicine-expands-bristol-myers-squibb-collaboration-with-new-diagnostic-target
Posted inMedical Technology

Foundation Medicine expands Bristol Myers Squibb collaboration with new diagnostic target

roche-boosts-diagnostics-offerings-with-$595m-saga-buyout
Posted inMedical Technology

Roche boosts diagnostics offerings with $595M Saga buyout

abbott-lowers-eps-guidance-on-exact-sciences-buy-as-shares-slide
Posted inMedical Technology

Abbott lowers EPS guidance on Exact Sciences buy as shares slide

Privacy Policy    Terms

Scroll to Top